Armata Pharmaceuticals (ARMP) Net Cash Flow (2016 - 2018)
Historic Net Cash Flow for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to $2.4 million.
- Armata Pharmaceuticals' Net Cash Flow rose 19097.57% to $2.4 million in Q4 2018 from the same period last year, while for Dec 2018 it was $1.3 million, marking a year-over-year increase of 32072.54%. This contributed to the annual value of -$4.5 million for FY2024, which is 18502.23% down from last year.
- Latest data reveals that Armata Pharmaceuticals reported Net Cash Flow of $2.4 million as of Q4 2018, which was up 19097.57% from -$2.1 million recorded in Q3 2018.
- In the past 5 years, Armata Pharmaceuticals' Net Cash Flow ranged from a high of $10.0 million in Q1 2015 and a low of -$3.9 million during Q1 2014
- Over the past 5 years, Armata Pharmaceuticals' median Net Cash Flow value was -$2.5 million (recorded in 2015), while the average stood at -$896650.0.
- In the last 5 years, Armata Pharmaceuticals' Net Cash Flow crashed by 264125.87% in 2014 and then soared by 35622.45% in 2015.
- Quarter analysis of 5 years shows Armata Pharmaceuticals' Net Cash Flow stood at -$3.2 million in 2014, then increased by 26.15% to -$2.4 million in 2015, then skyrocketed by 173.68% to $1.7 million in 2016, then crashed by 248.68% to -$2.6 million in 2017, then soared by 190.98% to $2.4 million in 2018.
- Its Net Cash Flow stands at $2.4 million for Q4 2018, versus -$2.1 million for Q3 2018 and -$2.1 million for Q2 2018.